SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11964529
Source:
http://linkedlifedata.com/resource/pubmed/id/11964529
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001758
,
umls-concept:C0008976
,
umls-concept:C0017431
,
umls-concept:C0034656
,
umls-concept:C0039593
,
umls-concept:C0162643
,
umls-concept:C0683598
,
umls-concept:C1963724
pubmed:issue
5
pubmed:dateCreated
2002-4-19
pubmed:abstractText
To assess the respective value of phenotype versus genotype versus standard of care for choosing antiretroviral therapy in patients failing protease inhibitor-containing regimens.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0269-9370
pubmed:author
pubmed-author:Brun-VézinetFrançoiseF
,
pubmed-author:ClavelFrançoisF
,
pubmed-author:CostagliolaDominiqueD
,
pubmed-author:DescampsDianeD
,
pubmed-author:GirardPierre-MariePM
,
pubmed-author:GuiramandSoniaS
,
pubmed-author:LamotteClaireC
,
pubmed-author:MatheronSophieS
,
pubmed-author:MeynardJean-LucJL
,
pubmed-author:Morand-JoubertLaurenceL
,
pubmed-author:Narval Trial Group
,
pubmed-author:PeytavinGillesG
,
pubmed-author:RaceEstherE
,
pubmed-author:VrayMurielM
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
727-36
pubmed:dateRevised
2010-4-12
pubmed:meshHeading
pubmed-meshheading:11964529-Anti-HIV Agents
,
pubmed-meshheading:11964529-CD4 Lymphocyte Count
,
pubmed-meshheading:11964529-Drug Prescriptions
,
pubmed-meshheading:11964529-Drug Resistance, Viral
,
pubmed-meshheading:11964529-Drug Tolerance
,
pubmed-meshheading:11964529-Genotype
,
pubmed-meshheading:11964529-HIV Infections
,
pubmed-meshheading:11964529-HIV Protease Inhibitors
,
pubmed-meshheading:11964529-HIV-1
,
pubmed-meshheading:11964529-Humans
,
pubmed-meshheading:11964529-Patient Compliance
,
pubmed-meshheading:11964529-Phenotype
,
pubmed-meshheading:11964529-Prospective Studies
,
pubmed-meshheading:11964529-Reverse Transcriptase Inhibitors
,
pubmed-meshheading:11964529-Treatment Failure
,
pubmed-meshheading:11964529-Viral Load
pubmed:year
2002
pubmed:articleTitle
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.
pubmed:affiliation
INSERM SC4, Hôpital Saint-Antoine, Paris, France.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study